{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:36:33Z","timestamp":1790091393597,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:00:00Z","timestamp":1746316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:00:00Z","timestamp":1746316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science Centre, Poland","award":["DEC-2021\/05\/X\/NZ4\/01805"],"award-info":[{"award-number":["DEC-2021\/05\/X\/NZ4\/01805"]}]},{"name":"Pomeranian Medical University , Poland","award":["FSN-318-03\/22"],"award-info":[{"award-number":["FSN-318-03\/22"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00466-9","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T15:11:58Z","timestamp":1746371518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Identification of an intestinal microbiota enterotypes in ageing man diagnosed with benign prostatic hyperplasia (BPH)"],"prefix":"10.1038","volume":"15","author":[{"given":"Weronika","family":"Ratajczak-Zacharko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Skonieczna-\u017bydecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Laszczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olimpia","family":"Sipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lubkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,4]]},"reference":[{"key":"466_CR1","doi-asserted-by":"publisher","first-page":"16031","DOI":"10.1038\/nrdp.2016.31","volume":"2","author":"B Chughtai","year":"2016","unstructured":"Chughtai, B. et al. Benign prostatic hyperplasia. Nat. Rev. Dis. Primers. 2, 16031. https:\/\/doi.org\/10.1038\/nrdp.2016.31 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"466_CR2","doi-asserted-by":"publisher","first-page":"e754","DOI":"10.1016\/S2666-7568(22)00213-6","volume":"3","author":"AF Awedew","year":"2022","unstructured":"Awedew, A. F. et al. The global, regional, and National burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the global burden of disease study 2019. Lancet Healthy Longev. 3, e754\u2013e776 (2022).","journal-title":"Lancet Healthy Longev."},{"key":"466_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11884-019-00566-z","volume":"15","author":"A Cho","year":"2020","unstructured":"Cho, A., Chughtai, B. & Te, A. E. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr. Bladder Dysfunct. Rep. 15, 60\u201365 (2020).","journal-title":"Curr. Bladder Dysfunct. Rep."},{"key":"466_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4103\/0970-1591.127856","volume":"30","author":"MJ Speakman","year":"2014","unstructured":"Speakman, M. J. & Cheng, X. Management of the complications of BPH\/BOO. Indian J. Urol. 30, 208\u2013213 (2014).","journal-title":"Indian J. Urol."},{"key":"466_CR5","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.juro.2009.06.047","volume":"182","author":"S Loeb","year":"2009","unstructured":"Loeb, S. et al. Prostate volume changes over time: results from the Baltimore longitudinal study of aging. J. Urol. 182, 1458\u20131462 (2009).","journal-title":"J. Urol."},{"key":"466_CR6","doi-asserted-by":"publisher","unstructured":"Gacci, M. et al. Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study. BMC Urol. 17 https:\/\/doi.org\/10.1186\/s12894-017-0211-9 (2017).","DOI":"10.1186\/s12894-017-0211-9"},{"key":"466_CR7","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00345-020-03106-1","volume":"38","author":"C De Nunzio","year":"2020","unstructured":"De Nunzio, C., Salonia, A., Gacci, M. & Ficarra, V. Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia. World J. Urol. 38, 2771\u20132779 (2020).","journal-title":"World J. Urol."},{"key":"466_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41443-022-00569-1","volume":"35","author":"GI Russo","year":"2023","unstructured":"Russo, G. I. et al. The relationship between the gut microbiota, benign prostatic hyperplasia, and erectile dysfunction. Int. J. Impot. Res. 35, 350\u2013355 (2023).","journal-title":"Int. J. Impot. Res."},{"key":"466_CR9","first-page":"1","volume":"9","author":"LY Li","year":"2022","unstructured":"Li, L. Y. et al. Alterations of gut microbiota diversity, composition and metabonomics in testosterone-induced benign prostatic hyperplasia rats. Mil Med. Res. 9, 1\u201316 (2022).","journal-title":"Mil Med. Res."},{"key":"466_CR10","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.3390\/ijms24065904","volume":"24","author":"J An","year":"2023","unstructured":"An, J., Song, Y., Kim, S., Kong, H. & Kim, K. Alteration of gut microbes in benign prostatic hyperplasia model and finasteride treatment model. Int. J. Mol. Sci. 24, 5904. https:\/\/doi.org\/10.3390\/ijms24065904 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"466_CR11","doi-asserted-by":"publisher","first-page":"1248381","DOI":"10.3389\/fcimb.2023.1248381","volume":"13","author":"D Xia","year":"2023","unstructured":"Xia, D. et al. Association between gut microbiota and benign prostatic hyperplasia: a two-sample Mendelian randomization study. Front. Cell. Infect. Microbiol. 13, 1248381. https:\/\/doi.org\/10.3389\/fcimb.2023.1248381 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"466_CR12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/pros.24223","volume":"81","author":"K Takezawa","year":"2021","unstructured":"Takezawa, K. et al. The firmicutes\/bacteroidetes ratio of the human gut microbiota is associated with prostate enlargement. Prostate 81, 1287\u20131293 (2021).","journal-title":"Prostate"},{"key":"466_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/bju.14972","volume":"125","author":"B Holland","year":"2020","unstructured":"Holland, B. et al. The effect of the urinary and faecal microbiota on lower urinary tract symptoms measured by the international prostate symptom score: analysis utilising next-generation sequencing. BJU Int. 125, 905\u2013910 (2020).","journal-title":"BJU Int."},{"key":"466_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.prnil.2022.03.004","volume":"10","author":"M Miyake","year":"2022","unstructured":"Miyake, M. et al. Prostate diseases and Microbiome in the prostate, gut, and urine. Prostate Int. 10, 96\u2013107 (2022).","journal-title":"Prostate Int."},{"key":"466_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.urology.2017.08.039","volume":"111","author":"DM Golombos","year":"2018","unstructured":"Golombos, D. M. et al. The role of gut Microbiome in the pathogenesis of prostate cancer: a prospective, pilot study. Urology 111, 122\u2013128 (2018).","journal-title":"Urology"},{"key":"466_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3892\/or.2023.8560","volume":"49","author":"B Xia","year":"2023","unstructured":"Xia, B., Wang, J., Zhang, D. & Hu, X. The human Microbiome links to prostate cancer risk and treatment (Review). Oncol. Rep. 49, 123. https:\/\/doi.org\/10.3892\/or.2023.8560 (2023).","journal-title":"Oncol. Rep."},{"key":"466_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4111\/icu.20220370","volume":"64","author":"HJ Yang","year":"2023","unstructured":"Yang, H. J. & Kim, J. H. Role of Microbiome and its metabolite, short chain fatty acid in prostate cancer. Investig Clin. Urol. 64, 3\u201312 (2023).","journal-title":"Investig Clin. Urol."},{"key":"466_CR18","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/cancers15051375","volume":"15","author":"K Fujita","year":"2023","unstructured":"Fujita, K. et al. The gut-Prostate axis: A new perspective of prostate Cancer biology through the gut Microbiome. Cancers 15, 1375. https:\/\/doi.org\/10.3390\/cancers15051375 (2023).","journal-title":"Cancers"},{"key":"466_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11684-019-0731-7","volume":"15","author":"S Ohadian Moghadam","year":"2021","unstructured":"Ohadian Moghadam, S. & Momeni, S. A. Human Microbiome and prostate cancer development: current insights into the prevention and treatment. Front. Med. 15, 11\u201332 (2021).","journal-title":"Front. Med."},{"key":"466_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/pros.10084","volume":"52","author":"G Kramer","year":"2002","unstructured":"Kramer, G. et al. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 52, 43\u201358 (2002).","journal-title":"Prostate"},{"key":"466_CR21","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","volume":"51","author":"G Kramer","year":"2007","unstructured":"Kramer, G., Mitteregger, D. & Marberger, M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur. Urol. 51, 1202\u20131216 (2007).","journal-title":"Eur. Urol."},{"key":"466_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","volume":"473","author":"M Arumugam","year":"2011","unstructured":"Arumugam, M. et al. Enterotypes of the human gut Microbiome. Nature 473, 174\u2013180 (2011).","journal-title":"Nature"},{"key":"466_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-84928-w","volume":"11","author":"V Palmas","year":"2021","unstructured":"Palmas, V. et al. Gut microbiota markers associated with obesity and overweight in Italian adults. Sci. Rep. 11, 1\u201314 (2021).","journal-title":"Sci. Rep."},{"key":"466_CR24","doi-asserted-by":"publisher","first-page":"1097892","DOI":"10.3389\/fmicb.2023.1097892","volume":"14","author":"M Lv","year":"2023","unstructured":"Lv, M. et al. Analysis of the relationship between the gut microbiota enterotypes and colorectal adenoma. Front. Microbiol. 14, 1097892. https:\/\/doi.org\/10.3389\/fmicb.2023.1097892 (2023).","journal-title":"Front. Microbiol."},{"key":"466_CR25","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3390\/metabo13121182","volume":"13","author":"M Bartsch","year":"2023","unstructured":"Bartsch, M., Hahn, A. & Berkemeyer, S. Bridging the gap from enterotypes to personalized dietary recommendations: A metabolomics perspective on Microbiome research. Metabolites 13, 1182. https:\/\/doi.org\/10.3390\/metabo13121182 (2023).","journal-title":"Metabolites"},{"key":"466_CR26","doi-asserted-by":"publisher","first-page":"239629","DOI":"10.3389\/fcimb.2017.00047","volume":"7","author":"ACF de Moraes","year":"2017","unstructured":"de Moraes, A. C. F. et al. Enterotype May drive the dietary-associated cardiometabolic risk factors. Front. Cell. Infect. Microbiol. 7, 239629. https:\/\/doi.org\/10.3389\/fcimb.2017.00047 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"466_CR27","doi-asserted-by":"publisher","unstructured":"Bulygin, I. et al. Absence of enterotypes in the human gut microbiomes reanalyzed with non-linear dimensionality reduction methods. PeerJ 11 https:\/\/doi.org\/10.7717\/peerj.15838 (2023).","DOI":"10.7717\/peerj.15838"},{"key":"466_CR28","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.3390\/nu14122456","volume":"14","author":"D Campaniello","year":"2022","unstructured":"Campaniello, D. et al. How diet and physical activity modulate gut microbiota: evidence, and perspectives. Nutrients 14, 2456. https:\/\/doi.org\/10.3390\/nu14122456 (2022).","journal-title":"Nutrients"},{"key":"466_CR29","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/ismej.2011.41","volume":"5","author":"DPR Herlemann","year":"2011","unstructured":"Herlemann, D. P. R. et al. Transitions in bacterial communities along the 2000 Km salinity gradient of the Baltic sea. ISME J. 5, 1571\u20131579 (2011).","journal-title":"ISME J."},{"key":"466_CR30","unstructured":"Lefcheck, J. Diversity as effective numbers \u2013 SAMPLE (ECOLOGY). https:\/\/jonlefcheck.net\/2012\/10\/23\/diversity-as-effective-numbers\/ (2012)."},{"key":"466_CR31","doi-asserted-by":"publisher","unstructured":"Katongole, P., Sande, O. J., Joloba, M., Reynolds, S. J. & Niyonzima, N. The human Microbiome and its link in prostate cancer risk and pathogenesis. Infect. Agent Cancer. 15 https:\/\/doi.org\/10.1186\/s13027-020-00319-2 (2020).","DOI":"10.1186\/s13027-020-00319-2"},{"key":"466_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41391-018-0061-x","volume":"21","author":"KS Sfanos","year":"2018","unstructured":"Sfanos, K. S. et al. Compositional differences in Gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Prostate Cancer Prostatic Dis. 21, 539\u2013548 (2018).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"466_CR33","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.eururo.2018.06.033","volume":"74","author":"MA Liss","year":"2018","unstructured":"Liss, M. A. et al. Metabolic biosynthesis pathways identified from fecal Microbiome associated with prostate cancer. Eur. Urol. 74, 575\u2013582 (2018).","journal-title":"Eur. Urol."},{"key":"466_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/2090598X.2020.1761674","volume":"18","author":"A Haddad","year":"2020","unstructured":"Haddad, A. et al. Inflammatory bowel disease and prostate cancer risk: A systematic review. Arab. J. Urol. 18, 207\u2013212 (2020).","journal-title":"Arab. J. Urol."},{"key":"466_CR35","doi-asserted-by":"crossref","unstructured":"Burns, J. A. et al. Inflammatory bowel disease and the risk of prostate cancer. Eur. Uro.l 75, 846\u2013852 (2019).","DOI":"10.1016\/j.eururo.2018.11.039"},{"key":"466_CR36","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/ajg.2013.249","volume":"108","author":"T Jess","year":"2013","unstructured":"Jess, T., Horv\u00e1th-Puh\u00f3, E., Fallingborg, J., Rasmussen, H. H. & Jacobsen, B. A. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study. Am. J. Gastroenterol. 108, 1869\u20131876 (2013).","journal-title":"Am. J. Gastroenterol."},{"key":"466_CR37","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1097\/MIB.0000000000001240","volume":"23","author":"J So","year":"2017","unstructured":"So, J. et al. Cancer risk in 2621 Chinese patients with inflammatory bowel disease: A Population-based cohort study. Inflamm. Bowel Dis. 23, 2061\u20132068 (2017).","journal-title":"Inflamm. Bowel Dis."},{"key":"466_CR38","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/ecco-jcc\/jjx040","volume":"11","author":"YS Jung","year":"2017","unstructured":"Jung, Y. S., Han, M., Park, S., Kim, W. H. & Cheon, J. H. Cancer risk in the early stages of inflammatory bowel disease in Korean patients: A nationwide Population-based study. J. Crohns Colitis. 11, 954\u2013962 (2017).","journal-title":"J. Crohns Colitis"},{"key":"466_CR39","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.3390\/biomedicines10112676","volume":"10","author":"KY Tsai","year":"2022","unstructured":"Tsai, K. Y. et al. Exploring the association between gut and urine microbiota and prostatic disease including benign prostatic hyperplasia and prostate Cancer using 16S rRNA sequencing. Biomedicines 10, 2676. https:\/\/doi.org\/10.3390\/biomedicines10112676 (2022).","journal-title":"Biomedicines"},{"key":"466_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/CEG.S186097","volume":"12","author":"BP Vaughn","year":"2019","unstructured":"Vaughn, B. P. et al. A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis. Clin. Exp. Gastroenterol. 12, 9\u201319 (2019).","journal-title":"Clin. Exp. Gastroenterol."},{"key":"466_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1875796","volume":"13","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Blautia\u2014a new functional genus with potential probiotic properties? Gut Microbes. 13, 1\u201321 (2021).","journal-title":"Gut Microbes"},{"key":"466_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-47594-w","volume":"15","author":"SM Holmberg","year":"2024","unstructured":"Holmberg, S. M. et al. The gut commensal Blautia maintains colonic mucus function under low-fiber consumption through secretion of short-chain fatty acids. Nat. Commun. 15, 1\u201319 (2024).","journal-title":"Nat. Commun."},{"key":"466_CR43","doi-asserted-by":"publisher","first-page":"e2309255","DOI":"10.1002\/advs.202309255","volume":"11","author":"Y Niu","year":"2024","unstructured":"Niu, Y. et al. Blautia Coccoides is a newly identified bacterium increased by leucine deprivation and has a novel function in improving metabolic disorders. Adv. Sci. (Weinh). 11, e2309255. https:\/\/doi.org\/10.1002\/advs.202309255 (2024).","journal-title":"Adv. Sci. (Weinh)"},{"key":"466_CR44","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s12602-023-10044-y","volume":"15","author":"B Mao","year":"2023","unstructured":"Mao, B. et al. Potential probiotic properties of Blautia producta against Lipopolysaccharide-Induced acute liver injury. Probiotics Antimicrob. Proteins. 15, 785\u2013796 (2023).","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"466_CR45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.abf8403","volume":"374","author":"N Pernigoni","year":"2021","unstructured":"Pernigoni, N. et al. Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis. Science 374, 216\u2013224 (2021).","journal-title":"Science"},{"key":"466_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5387\/fms.2022-34","volume":"68","author":"R Honda-Takinami","year":"2022","unstructured":"Honda-Takinami, R. et al. Association between the presence of bacteria in prostate tissue and histopathology in biopsies from men not complaining of lower urinary tract symptoms. Fukushima J. Med. Sci. 68, 161. https:\/\/doi.org\/10.5387\/fms.2022-34 (2022).","journal-title":"Fukushima J. Med. Sci."},{"key":"466_CR47","doi-asserted-by":"publisher","first-page":"127596","DOI":"10.1016\/j.micres.2023.127596","volume":"281","author":"J Li","year":"2024","unstructured":"Li, J. et al. The human Microbiome and benign prostatic hyperplasia: current Understandings and clinical implications. Microbiol. Res. 281, 127596. https:\/\/doi.org\/10.1016\/j.micres.2023.127596 (2024).","journal-title":"Microbiol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00466-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T15:12:01Z","timestamp":1746371521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00466-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,4]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00466-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,4]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards and approved by the Bioethics Committee of the Pomeranian Medical University, Szczecin (approval number KB-0012\/139\/17). All participants gave written informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"15603"}}